111 (YI) Cash from Financing Activities (2017 - 2025)
111's (YI) quarterly Cash from Financing Activities came in at $3.8 million in Q4 2025, up 177.46% year-on-year from $1.4 million in Q4 2024, and up 312.72% quarter-over-quarter from $920000.0 in Q3 2025.
111 (YI) Cash from Financing Activities (2017 - 2025) Analysis & Trends
111 has disclosed Cash from Financing Activities across 9 years of filings, most recently posting $3.8 million for Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $3.8 million, up 177.46% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.7 million (up 95.17% YoY), and the FY2025 annual result was -$3.0 million, up 94.55% from the prior year.
- Cash from Financing Activities came in at $3.8 million for Q4 2025 at 111, up from $920000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $22.5 million in Q4 2021 to a low of -$27.9 million in Q1 2021.
- The 5-year median for Cash from Financing Activities is $937000.0 (2022), against an average of -$1.1 million.
- Across the five-year window, Cash from Financing Activities surged 364.25% in 2023 and sank 2100.82% in 2024, its largest moves.
- 111's Cash from Financing Activities stood at $22.5 million in 2021, then sank by 85.94% to $3.2 million in 2022, then sank by 92.25% to $245000.0 in 2023, then tumbled by 2100.82% to -$4.9 million in 2024, then soared by 177.46% to $3.8 million in 2025.
- The last three Cash from Financing Activities figures came in at $3.8 million (Q4 2025), $920000.0 (Q3 2025), and $2.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.82 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.98 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -483.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 120.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 51.08 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 3.80 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 347,627.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.80 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 920,000.00 |
| Sep 30, 2025 | 920,000.00 |
| Jun 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | 2.61 Mn |
| Mar 31, 2025 | -10.06 Mn |
| Mar 31, 2025 | -10.06 Mn |
| Dec 31, 2024 | -4.90 Mn |
| Dec 31, 2024 | -4.90 Mn |
| Sep 30, 2024 | -15.75 Mn |
| Sep 30, 2024 | -15.75 Mn |
| Jun 30, 2024 | -14.38 Mn |
| Jun 30, 2024 | -14.38 Mn |
| Mar 31, 2024 | -21.53 Mn |
| Mar 31, 2024 | -21.53 Mn |
| Dec 31, 2023 | 245,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Sep 30, 2023 | 15.14 Mn |
| Sep 30, 2023 | 15.14 Mn |